Phase 1 Randomized Controlled Trial of the Safety and Immunogenicity of the SARS-CoV-2 (Omicron BA.5) mRNA-CR-04 Vaccine in Adults 18-49 Years of Age.
- DOI
- 10.1093/ofid/ofaf689
- Published
- 2025 Dec
- Container
- Open forum infectious diseases
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ofid/ofaf689,
title = {Phase 1 Randomized Controlled Trial of the Safety and Immunogenicity of the SARS-CoV-2 (Omicron BA.5) mRNA-CR-04 Vaccine in Adults 18-49 Years of Age.},
author = {Naficy A and Venken M and Xi Y and Loughrey M and Maruggi G and Sharma H and Aggarwal K and Brune D and Nguyen BY},
year = {2025},
journal = {Open forum infectious diseases},
doi = {10.1093/ofid/ofaf689},
url = {https://doi.org/10.1093/ofid/ofaf689}
}RIS
TY - JOUR TI - Phase 1 Randomized Controlled Trial of the Safety and Immunogenicity of the SARS-CoV-2 (Omicron BA.5) mRNA-CR-04 Vaccine in Adults 18-49 Years of Age. AU - Naficy A AU - Venken M AU - Xi Y AU - Loughrey M AU - Maruggi G AU - Sharma H AU - Aggarwal K AU - Brune D AU - Nguyen BY PY - 2025 JO - Open forum infectious diseases DO - 10.1093/ofid/ofaf689 UR - https://doi.org/10.1093/ofid/ofaf689 ER -
APA
A, N., M, V., Y, X., M, L., G, M., H, S., K, A., D, B., & BY, N. (2025). Phase 1 Randomized Controlled Trial of the Safety and Immunogenicity of the SARS-CoV-2 (Omicron BA.5) mRNA-CR-04 Vaccine in Adults 18-49 Years of Age.. Open forum infectious diseases. https://doi.org/10.1093/ofid/ofaf689
Source records
- pubmed · retrieved 2026-09-25T21:13:10.556Z